NCT06742203View on ClinicalTrials.gov

WPMDE1 - Whey Protein Milk-Derived Exosomes Among Healthy Subjects

NACompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

October 1, 2023

Primary Completion Date

March 1, 2024

Study Completion Date

April 1, 2024

Conditions
IBD
Interventions
DIETARY_SUPPLEMENT

Whey Protein Milk-Derived EVs

WPMDE1 - Whey Protein Milk-Derived EVs, is a white powder obtained by filtration, concentration, and dehydrating whey solution, with the addition of sweeteners and flavorings to balance the taste. The WPMDE1 contains a known concentration of EVs (also known as milk exosomes).

Trial Locations (1)

Unknown

Hadassah Medical Center, Jerusalem

All Listed Sponsors
lead

Exosomm Ltd.

INDUSTRY

NCT06742203 - WPMDE1 - Whey Protein Milk-Derived Exosomes Among Healthy Subjects | Biotech Hunter | Biotech Hunter